drugset / Trial / NCT01958489

A Study of Evacetrapib in Japanese and Non-Japanese Participants

NCT01958489

Phase 1 Completed 24 enrolled Eli Lilly and Company
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The main purpose of this study is to look at the effect of evacetrapib on pravastatin levels in the blood when both drugs are taken at the same time. The study will also assess how well the body handles evacetrapib and pravastatin when given at the same time. This study has two periods in fixed order. Each participant will enroll in both periods. This study will last approximately 25 days, not including screening.

Timeline

Start
2013-10
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Evacetrapib Small molecule 130 mg Oral
Subject Pravastatin Small molecule 40 mg Oral

Indications

No indication recorded.